Peptides Through Life Stages
Pregnancy, breastfeeding, fertility, surgery, menopause, and the years when weight and muscle both start moving. These guides cover the circumstances that change the answer, where general guidance stops applying and where label language is either unusually specific or conspicuously silent. Several of them exist because the honest answer is that nothing has been measured in that population, which is worth knowing before anyone assumes the silence means safety.
Do GLP-1 Drugs Affect Your Other Medications? What the Labels Report
Four labels warn that slowed stomach emptying may affect oral medicines, yet they test only eight named drugs. What they report, including levothyroxine.
Does Tirzepatide Make Birth Control Less Effective? What the Label Says
What the tirzepatide label says about oral contraceptives, the four-week window after starting and after each dose increase, and why semaglutide's label differs.
Does Lifting Protect Muscle on a GLP-1? What Was Tested
What the exercise, protein and muscle-preservation studies on GLP-1 drugs actually tested, and what remains unanswered.
Does Kisspeptin Work for IVF? What the Trials Measured
What the egg-maturation trials measured, why kisspeptin-54 is not kisspeptin-10, and what remains untested.
Do GLP-1 Drugs Affect Sperm, Testosterone or Male Fertility? What Has Actually Been Measured
Two 2026 reviews counted 10 studies and 639 men. One randomized trial measured semen in 25 men. No study has recorded a pregnancy. What the evidence shows.
Do Copper Peptides Work for Menopausal Skin and Hair? What Has Been Measured
No copper peptide trial has enrolled postmenopausal women. The newest hair study ran in 18 people aged 18 to 40, on eyebrows, and published no numbers.
Should You Take a GLP-1 Before Trying to Conceive With PCOS?
A new study found fewer pregnancy complications in women with PCOS treated before conception. It cannot show the drug caused it, and the labels disagree on timing.
Are GLP-1 Drugs Safe for Teenagers? What the Trials Did Not Measure
Two GLP-1 drugs are approved from age 12. The trial behind that approval ran 68 weeks and measured BMI, not growth, not puberty and not bone density.
Can You Take Semaglutide While Breastfeeding? What Has Actually Been Measured
What human milk studies found for semaglutide and tirzepatide, what their labels say, and what remains unknown about milk supply and research-vial peptides.
Does Semaglutide Cause Muscle Loss? What Happens to Muscle, Skin, Hair and Bone
Lean tissue was 30 to 40% of weight lost in trials, and function held up. What preserves muscle has evidence behind it and is not sold in a vial.
Peptides Under 25: What Nobody Has Studied
Raising growth hormone accelerates bone maturation, so the compound sold to make you bigger may make you shorter. And nobody has studied any of it under 25.
Peptides in Perimenopause: What Has Actually Been Studied
One group has real evidence and menopausal women were underrepresented in it. For everything else, a search for trials in this population returns nothing at all.
Peptides and Men in Midlife
Testosterone improved sexual function and not vitality. Clinically significant improvement reached 3% and 10% of men. The peptides bundled with it have nothing.
Peptides, Fertility and Pregnancy: What the Labels Say
Tirzepatide reduces oral contraceptive absorption and semaglutide does not. Fertility can return on both. Neither is stated alongside the other anywhere else.
Peptides and Drug-Tested Sport
Four years is the default sanction, the research label counts for nothing, and a compound does not need to be named to be prohibited. What actually applies.
Can GLP-1 Drugs Change Your Period?
Menstrual changes are on no GLP-1 label and in no trial. Four mechanisms, only one of which needs weight loss, and why some cycles return instead of stopping.
Peptides, Surgery and Anesthesia
The advice reversed. Holding the drug did not reliably empty the stomach, and one patient was still full after twelve days off it and a 32-hour fast.
Peptides After 65: What the Trials in Older Adults Found
The unusual case where evidence exists. A trial in older adults was stopped early, and a two-year study raised lean mass without improving strength or function.